Precedex Decision Will Impact FDA's Use Code System
The U.S. Food and Drug Administration's Aug. 18, 2014, decision[1] to accept Section VIII certifications for generic versions of Precedex, despite overlap between the labeled uses for these generic versions and...To view the full article, register now.
Already a subscriber? Click here to view full article